• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD SUZHOU (MDS) BD INTIMA-II Y 24GAX0.75IN PRN EC SLM NPVC; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD SUZHOU (MDS) BD INTIMA-II Y 24GAX0.75IN PRN EC SLM NPVC; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383083
Device Problem Fluid/Blood Leak (1250)
Patient Problem Erythema (1840)
Event Date 02/19/2024
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that bd intima-ii y 24gax0.75in prn ec slm npvc leaked.The following information was provided by the initial reporter, translated from chinese to english: on (b)(6) 2024, a nurse used a closed iv needle to administer anti-inflammatory medication to a patient during the course of the infusion of the medication oozing out of the needle, and the patient developed symptoms of redness and swelling of the skin at the eye of the needle.So immediately pulled out the needle, change the injection site to re-injection, and then the patient's discomfort symptoms improved.
 
Event Description
No additional information provided.
 
Manufacturer Narrative
1.Dhr/bhr review(lot#3290314): 1)this batch of products were assembled at intima ii auto line 2 in november 2023, and packaged at r240 package line in november 2023.Work order quantity was (b)(4) ea.2)review the in-process test reports and outgoing test reports, and all test results meet the product specifications.3)review the production records with no nonconformance, deviation or rework activities.4)review the batch records, no material, process change.The sterilization process is normal, the bi sterility test is passed, and the eo residue test is passed, the products meet the requirement of bi sterility test before release, see the attachment pr# (b)(4) coc 2.No defective samples and photos have been received for the complaint.3.45psi leakage test is carried out on the retained sample of this batch, and no leakage is found.Please refer to (b)(4) attachment for the test report.4.No similar complaints have been received from other hospitals regarding this batch of products.Conclusion(s): there are no abnormalities in the manufacturing process, sterilization process and retained sample, and no similar complaints have been received from other hospitals about this batch of products.As no defective sample is received for analysis and confirmation, the root cause of the complained defects cannot be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INTIMA-II Y 24GAX0.75IN PRN EC SLM NPVC
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BD SUZHOU (MDS)
#5 baiyu road
suzhou industrial park
jiangsu 21502 1
CH  215021
Manufacturer (Section G)
BD (SUZHOU)
no. 5 baiyu road
suzhou industrial park
suzhou 21502 1
CH   215021
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key18906052
MDR Text Key337776858
Report Number3002601200-2024-00086
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier00382903830831
UDI-Public(01)00382903830831
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number383083
Device Lot Number3290314
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/22/2024
Initial Date FDA Received03/14/2024
Supplement Dates Manufacturer Received04/05/2024
Supplement Dates FDA Received04/15/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/17/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-